Trial intelligence / Profile preview

Concomitant chemoendocrine therapy vs sequential chemotherapy then endocrine therapy in first-line luminal B metastatic breast cancer

2016-004107-31Phase 3Terminated

Sponsor

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"

Start

Jan 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules

Countries

1